NYSEARCA:SBIO

ALPS Medical Breakthroughs ETF (SBIO) Price, Holdings, & News

$31.91
+0.31 (+0.98%)
(As of 04/22/2024 ET)
Today's Range
$31.58
$32.26
50-Day Range
$31.59
$38.69
52-Week Range
$23.21
$38.80
Volume
6,335 shs
Average Volume
12,345 shs
Market Capitalization
$102.10 million
Assets Under Management
$102.17 million
Dividend Yield
0.21%
Net Expense Ratio
0.50%
SBIO stock logo

About ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.

SBIO Stock Price History

SBIO ETF News Headlines

ALPS Medical Breakthroughs ETF (SBIO)
At first glance, this chart looks like nonsense…
We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”
How ETF Investors Can Take Advantage Of Deal Activity
Biotech ETF SBIO’s Momentum Strong to End 2023
Play US Gene Treatment Approval in SBIO
At first glance, this chart looks like nonsense…
We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”
SBIO - ALPS Medical Breakthroughs ETF
See More Headlines
Receive SBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ALPS Medical Breakthroughs ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
ALPS
Fund Name
ALPS Medical Breakthroughs ETF
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:SBIO
Inception Date
12/31/2014
Fund Manager
Ryan Mischker, Andrew Hicks
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
S-Network Medical Breakthroughs Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
97

Fund Statistics

Assets Under Management
$101.15 million
Average Daily Volume
$11,558.00
Discount/Premium
-0.02%

Administrator, Advisor and Custodian

Administrator
ALPS Fund Services, Inc.
Advisor
ALPS Advisors, Inc.
Custodian
State Street Bank and Trust Company
Distributor
ALPS Portfolio Solutions Distributor, Inc.
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
GTS

Options

Optionable
Optionable
Options Volume
17
Put Options
5
Call Options
12
Short Interest
12,300 shs

Miscellaneous

Beta
1.03
Creation Unit
50,000
Creation Fee
$500.00
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

ALPS Medical Breakthroughs ETF Expenses

TypeSBIOHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.50%0.56%0.54%0.50%0.51%
Other Expenses0.00%0.40%0.54%0.64%0.58%
Total Expense0.50%0.72%0.70%0.74%0.70%
Fee Waiver0.00%-0.53%-0.55%-0.68%-0.57%
Net Expense0.50%0.60%0.60%0.57%0.58%

ALPS Medical Breakthroughs ETF (SBIO) Holdings & Exposure


SBIO ETF - Frequently Asked Questions

How have SBIO shares performed in 2024?

ALPS Medical Breakthroughs ETF's stock was trading at $32.94 at the beginning of the year. Since then, SBIO shares have decreased by 3.1% and is now trading at $31.9077.
View the best growth stocks for 2024 here
.

What does SBIO invest in?

ALPS Medical Breakthroughs ETF is a equity fund issued by ALPS. SBIO focuses on health care investments and follows the S-Network Medical Breakthroughs Index. The fund's investments total to approximately $101.15 million assets under management.

What is the management fee for ALPS Medical Breakthroughs ETF?

ALPS Medical Breakthroughs ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for SBIO is 0.50%.

What other stocks do shareholders of ALPS Medical Breakthroughs ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ALPS Medical Breakthroughs ETF investors own include Micron Technology (MU), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Johnson & Johnson (JNJ), Novavax (NVAX), Alibaba Group (BABA), Cidara Therapeutics (CDTX) and Quest Diagnostics (DGX).

Who are ALPS Medical Breakthroughs ETF's major shareholders?

ALPS Medical Breakthroughs ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include Central Valley Advisors LLC (0.18%).

How do I buy shares of ALPS Medical Breakthroughs ETF?

Shares of SBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:SBIO) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners